Life Tech to Acquire Ion Torrent for up to $725M; Will Market PGM System for 'Mid-Scale' Sequencing

The company said that Ion Torrent's benchtop Personal Genome Machine, which is scheduled for commercial release later this year, is "highly complementary" to its capillary electrophoresis and SOLiD sequencing platforms and is "optimal for mid-scale sequencing projects, such as targeted and microbial sequencing."